PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
WEBApproximately 300,000 patients in the US will be eligible for the therapy. Roche’s Genentech acquires Regor Pharmaceuticals’ CDK inhibitors for $850m upfront. J&J and Legend share long-term results for Carvykti in phase 3 multiple myeloma study. Bristol Myers Squibb announces positive data for Sotyktu in moderate-to-severe psoriasis.
Pfizer and BioNTech share late-stage results for COVID-19/flu ...
WEBAug 16, 2024 · Pfizer and BioNTech have announced top-line results from a late-stage study of their mRNA-based combination vaccine for influenza and COVID-19. The partners have been evaluating the candidate against a licensed flu vaccine and their own licensed COVID-19 vaccine given at the same visit in more …
FDA approves Pfizer/BioNTech and Moderna’s updated COVID-19 …
WEBSep 12, 2023 · The US Food and Drug Administration (FDA) has approved updated COVID-19 vaccines from Pfizer/BioNTech and Moderna to more closely target currently circulating variants.
Pfizer’s Paxlovid given FDA permission to be prescribed by US ...
WEBJul 7, 2022 · The US Food and Drug Administration (FDA) has revised the Emergency Use Authorisation (EUA) for Paxlovid (nirmatrelvir and ritonavir), authorising pharmacists to prescribe the drug to eligible patients. Under the revision, state-licensed pharmacists will be able to prescribe the drug to patients testing positive for COVID-19, on the condition ...
Pfizer and BioNTech share positive results for Omicron-adapted …
WEBJun 27, 2022 · Pfizer and BioNTech have shared positive results from a phase 2/3 trial of two Omicron-adapted COVID-19 vaccine candidates. The data shows that a booster dose of both Omicron-adapted vaccines gave a considerably higher immune response against Omicron BA.1, compared to Pfizer/BioNTech’s current COVID-19 vaccine.
Keytruda gains eighth FDA approval this year - PMLiVE
WEBDec 7, 2021 · 2021 has been a good year for Keytruda (pembrolizumab), which has notched up more than 20 approvals across the world and is on track to bring in at least £17bn for Merck – known as MSD outside the US and Canada – this year alone.
PME - Home
WEBHow AI and digital innovations can help agencies and pharma support HCPs in the fight against COVID-19 - PME Supplement August 2020. As the realities of COVID-19 hit and lockdown restrictions came into force around the world, agencies and pharma suddenly found themselves embracing AI and digital innovations at an accelerated rate.
Moderna seeks full FDA approval for its COVID-19 vaccine
WEBJun 2, 2021 · Moderna is seeking a full US Food and Drug Administration (FDA) approval for its COVID-19 vaccine mRNA-1273, after gaining an emergency use authorisation (EUA) for the jab late last year.
AstraZeneca presents positive phase 3 results for Imfinzi ... - PMLiVE
WEBApr 18, 2023 · AstraZeneca’s (AZ) Imfinzi has shown promising results when used before and after surgery in resectable early-stage non-small cell lung cancer (NSCLC), according to new phase 3 data presented at the American Association for Cancer Research Annual Meeting. Interim results from the AEGEAN study, which is …
COVID-19 Pfizer/BioNTech booster approved by FDA and CDC
WEBSep 24, 2021 · After months of controversy, the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have given a green light to the COVID-19 booster programme in the US.